The Patent Finder

Allergy Research Group, LLC

Also on record
Records under this name other than patents Allergy Research Group, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Allergy Research Group, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,421,943Phospholipid compositions and use thereof to enhance spermatozoa motility, viability and resistance to oxydative damage
Formerly held
In force (reinstated)
 · USPTO record
In force (reinstated)USPTO record
US 8,877,239LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,717,734Chewable lipid supplements containing caffeine for increasing alertness, focus and energy
Formerly held
Lapsed on the fee record
Ended Aug 1, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 1, 2025USPTO record
US 10,874,681Oral lipid supplements for treating pain and fibromyalgia
Formerly held
Lapsed on the fee record
Ended Dec 29, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 29, 2024USPTO record
US 9,468,668Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders
Formerly held
Lapsed on the fee record
Ended Oct 18, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 18, 2024USPTO record
US 9,095,507Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
Formerly held
Lapsed on the fee record
Ended Aug 4, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 4, 2023USPTO record
US 10,117,885Chewable lipid supplements for treating pain and fibromyalgia
Formerly held
Lapsed on the fee record
Ended Nov 6, 2022 · USPTO record
Lapsed on the fee recordEnded Nov 6, 2022USPTO record
US 9,861,656Phospholipid compositions and use thereof to enhance spermatozoa motility and viability
Formerly held
Lapsed on the fee record
Ended Jan 9, 2022 · USPTO record
Lapsed on the fee recordEnded Jan 9, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited